These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 36327286

  • 21. Vasopressor treatment and mortality following nontraumatic subarachnoid hemorrhage: a nationwide electronic health record analysis.
    Williams G, Maroufy V, Rasmy L, Brown D, Yu D, Zhu H, Talebi Y, Wang X, Thomas E, Zhu G, Yaseen A, Miao H, Leon Novelo L, Zhi D, DeSantis SM, Zhu H, Yamal JM, Aguilar D, Wu H.
    Neurosurg Focus; 2020 May 01; 48(5):E4. PubMed ID: 32357322
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vasopressor and Inotrope Therapy in Cardiac Critical Care.
    Jentzer JC, Hollenberg SM.
    J Intensive Care Med; 2021 Aug 01; 36(8):843-856. PubMed ID: 32281470
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC, Beer KA.
    J Vet Emerg Crit Care (San Antonio); 2015 Aug 01; 25(1):48-54. PubMed ID: 25655726
    [Abstract] [Full Text] [Related]

  • 26. Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
    Pei XB, Ma PL, Li JG, Du ZH, Zhou Q, Lu ZH, Yun L, Hu B.
    Chin Med J (Engl); 2015 Apr 20; 128(8):1014-20. PubMed ID: 25881592
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
    Shabana A, Dholoo F, Banerjee P.
    Curr Heart Fail Rep; 2020 Dec 20; 17(6):438-448. PubMed ID: 33103204
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N.
    Semin Respir Crit Care Med; 2021 Feb 20; 42(1):59-77. PubMed ID: 32820475
    [Abstract] [Full Text] [Related]

  • 35. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
    Ruslan MA, Baharuddin KA, Noor NM, Yazid MB, Noh AYM, Rahman A.
    West J Emerg Med; 2021 Feb 16; 22(2):196-203. PubMed ID: 33856300
    [Abstract] [Full Text] [Related]

  • 36. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
    Schmitt CJ, Mattson AE, Brown CS, Mara KC, Cabrera D, Sandefur BJ, Wieruszewski ED.
    Am J Emerg Med; 2023 Mar 16; 65():104-108. PubMed ID: 36603354
    [Abstract] [Full Text] [Related]

  • 37. Adrenergic vasopressor agents and mechanical ventilation for the treatment of experimental septic shock.
    Tang W, Pakula JL, Weil MH, Noc M, Fukui M, Bisera J.
    Crit Care Med; 1996 Jan 16; 24(1):125-30. PubMed ID: 8565517
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 16; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.